AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE New | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Communication with the Office of the Inspector General regarding Conflicts of Interest for Compendia recognized by Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE New | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
Contact concerning FDA authority to manage drug shortages and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning S. 959, Pharmaceutical Compounding and Quality Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning HR 3204 (all sections) the Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE New | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.